drugset / Trial / NCT00770510
A Phase II/III Study of SEP-190 (Eszopiclone) in Patients With Primary Insomnia (Study 190-126)
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of this study is to investigate and evaluate the efficacy of Eszopiclone in Japanese participants with primary insomnia.
Timeline
- Start
- 2008-09
- Primary completion
- 2010-05
- Completion
- 2010-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eszopiclone | Small molecule | 1 mg | Oral |
| Subject | Eszopiclone | Small molecule | 2 mg | Oral |
| Subject | Eszopiclone | Small molecule | 3 mg | Oral |
| Comparator | Zolpidem | Small molecule | 10 mg | Oral |